SHUKRA MEDTECH LIMITED engages in the manufacturing, marketing, and export of pharmaceutical formulations in India and internationally. The company offers various products, such as antibiotics, anti biotics, macrolides, quinolones, anti bacterial, anti fungal, anti malarial, anti viral, anti protozoal, anti anthelmintic, sedative and tranquilliser, anti depressant, anti manic, anti emetic, anti ulcer, beta blockers, diuretics, analgesic, muscle relaxants, anti tuberculosis, vitamin products, anti allergics, corticosteroids, hyper and hypoglycemic, and other products.
SHUKRA MEDTECH LIMITED (SHUKRAPHAR) is listed on the NSE in the Healthcare sector, Drug Manufacturers - Specialty & Generic industry. The SHUKRAPHAR share price is ₹81.58 (+2.23% today), with a market capitalisation of ₹36B and a price-to-earnings (P/E) ratio of 104.6. MarketRipple tracks the SHUKRAPHAR investment thesis, the ripple-chain impact of market events on SHUKRA MEDTECH LIMITED, and the Healthcare sector outlook.
Open
₹81.50
High
₹83.30
Low
₹81.12
Prev. Close
₹79.80
52W High
₹84.20
52W Low
₹40.06
Day range
₹81.12–₹83.30
52-week range
₹40.06–₹84.20
Volume
909K
P/E
104.6
ROE
24.6%
D/E
0.06
Margin
45.4%
SHUKRA MEDTECH LIMITED (NSE: SHUKRAPHAR) is currently trading at ₹81.58 (+2.23%).
SHUKRA MEDTECH LIMITED's market capitalization is ₹36B.
SHUKRA MEDTECH LIMITED's price-to-earnings (P/E) ratio is 104.6.
SHUKRA MEDTECH LIMITED operates in the Healthcare sector (Drug Manufacturers - Specialty & Generic).